Rapport Therapeutics, Inc. RAPP Operating Income
Operating Income at other companies
Other financials
Where this comes from
Reported directly by Rapport Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.
The official record: Rapport Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Rapport Therapeutics, Inc.'s operating income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Rapport Therapeutics, Inc.'s operating income?
- Rapport Therapeutics, Inc. (RAPP) reported operating income of -$24.22M in Q1 2026.
- How has Rapport Therapeutics, Inc.'s operating income changed year-over-year?
- Rapport Therapeutics, Inc.'s operating income increased by 10.7% year-over-year, from -$27.11M to -$24.22M.
- What is the long-term trend for Rapport Therapeutics, Inc.'s operating income?
- Over 2 years (2023 to 2025), Rapport Therapeutics, Inc.'s operating income has grown at a 86.0% compound annual growth rate (CAGR), from -$36.18M to -$125.1M.
- What does operating income mean?
- Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.